In individuals with obesity, the dynamic equilibrium of lipid metabolism is disrupted, leading to excessive serum free fatty acids (FFAs), increased leptin, and decreased adiponectin levels, all of which can deteriorate insulin sensitivity and subsequently increase the risk of T2D [44]. Here, ADIPOQ is linked to obesity disorder.